Improved survival from ovarian cancer in patients treated in phase III trial active cancer centres in the UK.
Kitchener, H C
Clamp, Andrew R
Jayson, Gordon C
AffiliationThe Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester
MetadataShow full item record
AbstractOvarian cancer is the principal cause of gynaecological cancer death in developed countries, yet overall survival in the UK has been reported as being inferior to that in some Western countries. As there is a range of survival across the UK we hypothesised that in major regional centres, outcomes are equivalent to the best internationally.
CitationImproved survival from ovarian cancer in patients treated in phase III trial active cancer centres in the UK. 2016: Clin Oncol (R Coll Radiol)